Medipharm Labs Corp (LABS.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 11,448 | 11,808 | 10,806 | 12,042 | 9,798 |
| Cost of Goods | 8,886 | 8,478 | 6,624 | 8,426 | 6,678 |
| Gross Profit | 2,562 | 3,330 | 4,182 | 3,616 | 3,120 |
| Operating Expenses | 4,750 | 7,130 | 4,623 | 5,178 | 5,828 |
| Operating Income | -2,188 | -3,800 | -441 | -1,562 | -2,708 |
| Interest Expense | 16 | 12 | 16 | 21 | 235 |
| Other Income | 62 | 42 | 70 | -143 | 169 |
| Pre-tax Income | -2,142 | -3,770 | -387 | -1,726 | -2,774 |
| Net Income Continuous | -2,142 | -3,770 | -387 | -1,726 | -2,774 |
| Net Income | $-2,142 | $-3,770 | $-387 | $-1,726 | $-2,774 |
| EPS Basic Total Ops | -0.01 | -0.01 | 0.00 | -0.01 | -0.01 |
| EPS Basic Continuous Ops | -0.01 | -0.01 | 0.00 | -0.01 | -0.01 |
| EPS Diluted Total Ops | -0.01 | -0.01 | 0.00 | -0.01 | -0.01 |
| EPS Diluted Continuous Ops | -0.01 | -0.01 | 0.00 | -0.01 | -0.01 |
| EBITDA(a) | $-1,706 | $-3,339 | $54 | $-1,144 | $-2,021 |